Dr. Ron Daniels, Executive Director and Founder of the UK Sepsis Trust, discusses the four ways the UK Sepsis Trust looks to help improve outcomes from sepsis and patient care after diagnosis. Daniels explains the importance of using big data to discover sepsis trends within the population and highlights the benefits of using procalcitonin as a biomarker for pathogen identification within these patients.